Key points are not available for this paper at this time.
Psoriasis is an immune-mediated disease with a strong genetic component that brings many challenges to sick individuals, such as chronic illness, and which has multiple associated comorbidities like cardiovascular disease, metabolic syndrome, inflammatory bowel disease, and psychological disorders. Understanding the interplay between the innate and adaptative immune system has led to the discovery of specific cytokine circuits (Tumor Necrosis Factor-alpha (TNF-α), IL-23, IL-17), which has allowed scientists to discover new biomarkers that can be used as predictors of treatment response and pave the way for personalized treatments. In this review, we describe the footprint psoriasis leaves on the skin and beyond, key pathophysiological mechanisms, current available therapeutic options, and drawbacks faced by existing therapies, and we anticipate potential future perspectives that may improve the quality of life of affected individuals.
Building similarity graph...
Analyzing shared references across papers
Loading...
Alessandra-Mădălina Matei-Man
Meda Sandra Orăsan
Oana-Alina Hoteiuc
International Journal of Molecular Sciences
Iuliu Hațieganu University of Medicine and Pharmacy
Building similarity graph...
Analyzing shared references across papers
Loading...
Matei-Man et al. (Wed,) studied this question.
www.synapsesocial.com/papers/69da7da3387cf70698686beb — DOI: https://doi.org/10.3390/ijms242216095
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: